Gotowa bibliografia na temat „Dendritic cell”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Dendritic cell”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Dendritic cell"
Christie, J. M., i G. L. Westbrook. "Regulation of Backpropagating Action Potentials in Mitral Cell Lateral Dendrites by A-Type Potassium Currents". Journal of Neurophysiology 89, nr 5 (1.05.2003): 2466–72. http://dx.doi.org/10.1152/jn.00997.2002.
Pełny tekst źródłaLigon, Cheryl, Eunju Seong, Ethan J. Schroeder, Nicholas W. DeKorver, Li Yuan, Tammy R. Chaudoin, Yu Cai, Shilpa Buch, Stephen J. Bonasera i Jyothi Arikkath. "δ-Catenin engages the autophagy pathway to sculpt the developing dendritic arbor". Journal of Biological Chemistry 295, nr 32 (17.06.2020): 10988–1001. http://dx.doi.org/10.1074/jbc.ra120.013058.
Pełny tekst źródłaChen, Wei R., Gongyu Y. Shen, Gordon M. Shepherd, Michael L. Hines i Jens Midtgaard. "Multiple Modes of Action Potential Initiation and Propagation in Mitral Cell Primary Dendrite". Journal of Neurophysiology 88, nr 5 (1.11.2002): 2755–64. http://dx.doi.org/10.1152/jn.00057.2002.
Pełny tekst źródłaFujishima, Kazuto, Junko Kurisu, Midori Yamada i Mineko Kengaku. "βIII spectrin controls the planarity of Purkinje cell dendrites by modulating perpendicular axon-dendrite interactions". Development 147, nr 24 (24.11.2020): dev194530. http://dx.doi.org/10.1242/dev.194530.
Pełny tekst źródłaKalb, R. G. "Regulation of motor neuron dendrite growth by NMDA receptor activation". Development 120, nr 11 (1.11.1994): 3063–71. http://dx.doi.org/10.1242/dev.120.11.3063.
Pełny tekst źródłaNithianandam, Vanitha, i Cheng-Ting Chien. "Actin blobs prefigure dendrite branching sites". Journal of Cell Biology 217, nr 10 (24.07.2018): 3731–46. http://dx.doi.org/10.1083/jcb.201711136.
Pełny tekst źródłaSharp, D. J., W. Yu i P. W. Baas. "Transport of dendritic microtubules establishes their nonuniform polarity orientation." Journal of Cell Biology 130, nr 1 (1.07.1995): 93–103. http://dx.doi.org/10.1083/jcb.130.1.93.
Pełny tekst źródłaGrueber, Wesley B., Lily Y. Jan i Yuh Nung Jan. "Tiling of the Drosophila epidermis by multidendritic sensory neurons". Development 129, nr 12 (15.06.2002): 2867–78. http://dx.doi.org/10.1242/dev.129.12.2867.
Pełny tekst źródłaLin, Chin-Hsien, Hsun Li, Yi-Nan Lee, Ying-Ju Cheng, Ruey-Meei Wu i Cheng-Ting Chien. "Lrrk regulates the dynamic profile of dendritic Golgi outposts through the golgin Lava lamp". Journal of Cell Biology 210, nr 3 (27.07.2015): 471–83. http://dx.doi.org/10.1083/jcb.201411033.
Pełny tekst źródłaLeung, Donald Y. M., Harold S. Nelson, Stanley J. Szefler i William W. Busse. "Langerhans cell–like dendritic cells and inflammatory dendritic epidermal cell–like dendritic cells induce distinct T-cell responses". Journal of Allergy and Clinical Immunology 113, nr 5 (maj 2004): 803. http://dx.doi.org/10.1016/j.jaci.2004.03.025.
Pełny tekst źródłaRozprawy doktorskie na temat "Dendritic cell"
Carnathan, Diane Gail Vilen Barbara J. "Dendritic cell regulation of B cells". Chapel Hill, N.C. : University of North Carolina at Chapel Hill, 2007. http://dc.lib.unc.edu/u?/etd,1200.
Pełny tekst źródłaTitle from electronic title page (viewed Mar. 26, 2008). "... in partial fulfillment of the requirements for the degree of Master of Science in the Department of Microbiology and Immunology, School of Medicine." Discipline: Microbiology and Immunology; Department/School: Medicine.
Liu, Hao. "Dendritic cell development directed by stromal cells". Thesis, University of York, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.516409.
Pełny tekst źródłaGreensmith, Julie. "The dendritic cell algorithm". Thesis, Nottingham Trent University, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.444619.
Pełny tekst źródłaKavikondala, Sushma. "Dendritic cell and B cell interactions in systemic lupuserythematosus". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2007. http://hub.hku.hk/bib/B39793710.
Pełny tekst źródłaKavikondala, Sushma. "Dendritic cell and B cell interactions in systemic lupus erythematosus". View the Table of Contents & Abstract, 2007. http://sunzi.lib.hku.hk/hkuto/record/B39711523.
Pełny tekst źródłaRigby, Rachael Jane. "Intestinal dendritic cells : characterisation of the colonic dendritic cell population and identification of potential precursors". Thesis, Imperial College London, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.407134.
Pełny tekst źródłaJavorovic, Miran. "T-Cell Stimulation by Melanoma RNA-Pulsed Dendritic Cells". Diss., lmu, 2004. http://nbn-resolving.de/urn:nbn:de:bvb:19-30569.
Pełny tekst źródłaPérez, Zsolt Daniel. "New therapeutic strategies targeting dendritic cell-mediated dissemination of enveloped viruses". Doctoral thesis, Universitat Autònoma de Barcelona, 2020. http://hdl.handle.net/10803/669547.
Pełny tekst źródłaLas células dendríticas (DCs) son clave en la inducción de respestas inmunitarias adaptativas gracias a su capacidad de capturar, procesar y presentar antígenos derivados de patógenos a los linfocitos T. Sin embargo, estas células también podrían contribuir a la diseminación inicial del VIH-1 a través de la captura de partículas virales y de su transmisión a las células T CD4+ diana, un proceso conocido como trans-infección. Este mecanismo se basa en la expresión del receptor Siglec-1 (CD169), que reconoce gangliósidos sialilados en la membrana viral. Los niveles de Siglec-1 aumentan en DCs estimuladas con interferón-alfa (IFN-α) y lipopolisacárido (LPS), factores immuno-activadores presentes durante el curso de la infección por VIH-1. En este trabajo, hemos demostrado que el IFN-α secretado por DCs plasmacitoides (pDCs) infectadas por VIH-1, así como el IFN-α autocrino secretado por células mieloides en respuesta a LPS, aumentan la expresión de Siglec-1 en DCs. Además, las pDCs provenientes de mujeres secretan cantidades superiores de IFN-α que las derivadas de hombres, poniendo de manifiesto la relevancia de estudiar la trans-infección del VIH-1 en tejidos clave para la adquisición del virus en mujeres. Por lo tanto, también hemos estudiado el papel de Siglec-1 en la transmisión del VIH-1 por parte de DCs primarias aisladas directamente de tejido cervical, identificando una población de DCs cervicales que expresan Siglec-1 y capturan partículas de VIH-1 a través de este receptor. Esta capacidad aumenta con la activación por IFN-α. Además, la transmisión célula-célula del VIH-1 por células mieloides del cérvix se puede bloquear de forma eficiente con un anticuerpo monoclonal (mAb) dirigido contra Siglec-1. Se han producido cinco nuevos clones, que han demostrado tener una alta afinidad por diferentes epítopos localizados en la región N-terminal de Siglec-1. Además, bloquean de forma eficaç la captura y trans-infección del VIH-1 por DCs, de forma que podrían ser un posible componente en estrategias microbicidas dirigidas contra este tipo de transmisión viral célula-célula. Además del VIH-1, las DCs pueden jugar un papel importante en la patogénesis de otros virus, como los filovirus Ébola y Marburg. A diferencia del VIH-1, las DCs son permisivas a la infección por filovirus y son dianas tempranas en lapatogénesis viral. Los factores celulares implicados en la entrada de filovirus en DCs no han sido totalmente caracterizados, pero tanto Ébola como Marburg son virus envueltos que incorporan gangliósidos sialilados durante el proceso de budding. Además, los factores que activan la expresión de Siglec-1 como IFN-α y LPS se han encontrado durante la infección por el virus de Ébola. Por tanto, en esta tesis hemos estudiado el papel de Siglec-1 en la entrada de filovirus en DCs. Hemos encontrado que Siglec-1 está implicado en la captura de partículas no infecciosas de Ébola (VLPs) por parte de estas células, especialmente tras la activación por IFN-α y LPS. Además, las VLPs capturadas se acumulan en el mismo compartimento en el que previamente se había detectado VIH-1. Siglec-1 también facilita la entrada citoplásmica del virus en las DCs, así que hemos determinado la capacidad de los nuevos mAbs contra Siglec-1 para interferir en este proceso, y hemos visto que dichos mAbs bloquean tanto la captura como la entrada citoplásmica de VLPs de Ébola en células mieloides activadas. En general, la actividad de los mAbs contra Siglec-1 inhibe el acceso de retrovirus y filovirus en las células mieloides, cosa que indica su potencial uso como agentes antivirales de amplio espectro.
Dendritic cells are key inducers of specific adaptive immune responses due to their capacity to capture, process and present pathogen-derived antigens to T lymphocytes. However, they might also contribute to early HIV-1 dissemination by capturing HIV-1 particles and transmitting them to target CD4+ T cells, a process known as trans-infection. This mechanism relies on the expression of Siglec-1 receptor (CD169), which recognizes sialylated gangliosides on the viral membrane. Siglec-1 is potently up-regulated upon dendritic cell stimulation with interferon-alpha and lipopolysaccharide, which are both immune-activating factors present during the course of HIV-1 infection. Here, we demonstrated that interferon-alpha secreted by HIV-1-infected plasmacytoid dendritic cells and autocrine interferon-alpha secreted by myeloid cells in response to lipopolysaccharide up-regulate Siglec-1 on dendritic cells. Importantly, plasmacytoid dendritic cells derived from women secreted higher amounts of interferon-alpha than those derived from men, highlighting the relevance of studying HIV-1 trans-infection in key female tissues for HIV-1 acquisition. Thus, we next studied the role of Siglec-1 in HIV-1 transmission mediated by primary dendritic cells directly isolated from cervical tissues, identifying a subset of cervical myeloid cells that expressed Siglec-1 and captured HIV-1 particles in a Siglec-1-dependent manner. This capacity was enhanced upon activation with interferon-alpha. Moreover, HIV-1 cell-to-cell transmission mediated by these cells could be efficiently blocked using an anti-Siglec-1 monoclonal antibody, indicating the potential use of antibodies directed against Siglec-1 in prevention of sexually transmitted HIV-1 acquisition in women. Thus, we generated a set of new anti-Siglec-1 monoclonal antibodies with the capacity to block dendritic cell-mediated HIV-1 trans-infection. Five new clones were produced, demonstrating high affinity for different epitopes located in the N-terminal region of Siglec-1 receptor. Moreover, they efficiently blocked HIV-1 capture and trans-infection mediated by dendritic cells, indicating their potential use in microbicidal strategies targeting this type of viral cell-to-cell transmission. Aside from HIV-1, dendritic cells can play important roles in the pathogenesis of other viruses, including Ebola and Marburg filoviruses. In contrast to HIV-1, dendritic cells are permissive to filoviral infection and act as early targets in viral pathogenesis. The host factors governing filoviral entry into these cells are not fully characterized, but both Ebola and Marburg are enveloped viruses that incorporate sialylated gangliosides during the budding process. Moreover, Siglec-1-activating factors such as interferon-alpha and lipopolysaccharide have been found during Ebola virus disease. Thus, we investigated the role of Siglec-1 in filoviral entry into dendritic cells. We found that Siglec-1-mediated capture of non-infectious Ebola virus-like particles into these cells, especially upon interferon-alpha and lipopolysaccharide activation. Interestingly, captured Ebola virus-like particles accumulated in the same cellular compartment where HIV-1 was previously detected. Siglec-1 also facilitated Ebola cytoplasmic entry into dendritic cells, so we tested the capacity of novel anti-Siglec-1 monoclonal antibodies to interfere with this process. We found that capture and cytoplasmic entry of Ebola virus-like particles into activated myeloid cells was blocked by these novel antibodies. Overall, the activity of anti-Siglec-1 monoclonal antibodies inhibits the access of both retroviruses and filoviruses into myeloid cells and suggests their potential use as broad-spectrum antiviral agents.
Sarris, Milka. "Dynamics of helper T cell and regulatory T cell interactions with dendritic cells". Thesis, University of Cambridge, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.611896.
Pełny tekst źródłaMahmood, Sajid. "Diverse regulation of natural killer cell functions by dendritic cells". Public Library of Science, 2012. http://hdl.handle.net/1993/23963.
Pełny tekst źródłaOctober 2014
Książki na temat "Dendritic cell"
Robinson, Stephen P., i Andrew J. Stagg. Dendritic Cell Protocols. New Jersey: Humana Press, 2001. http://dx.doi.org/10.1385/1592591507.
Pełny tekst źródłaSegura, Elodie, i Nobuyuki Onai, red. Dendritic Cell Protocols. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-3606-9.
Pełny tekst źródłaNaik, Shalin H., red. Dendritic Cell Protocols. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60761-421-0.
Pełny tekst źródłaRescigno, Maria, red. Dendritic Cell Interactions with Bacteria. Cambridge: Cambridge University Press, 2001. http://dx.doi.org/10.1017/cbo9780511541551.
Pełny tekst źródła1968-, Rescigno Maria, red. Dendritic cell interactions with bacteria. Cambridge, UK: Cambridge University Press, 2007.
Znajdź pełny tekst źródłaLau, Colleen. Molecular control of dendritic cell development and function. [New York, N.Y.?]: [publisher not identified], 2015.
Znajdź pełny tekst źródłaWorkshop on Langerhans Cells (2nd 1988 Lyon, France). The Langerhans cell =: La cellule de Langerhans : proceedings of the Second Workshop on Langerhans Cells, held in Lyon (France), April 21-22, 1988. Paris, France: Editions INSERM, 1988.
Znajdź pełny tekst źródłaJones, David Allan. Dendritic cells, hapten presentation and lymph node cell activation following cutaneous sensitization in the mouse. [s.l.]: typescript, 1991.
Znajdź pełny tekst źródłaLewis, Kanako. Targeting of specific developmental pathways to understand dendritic cell heterogeneity and function. [New York, N.Y.?]: [publisher not identified], 2012.
Znajdź pełny tekst źródłaGreg, Stuart, Spruston Nelson i Häusser Michael, red. Dendrites. Wyd. 2. Oxford: Oxford University Press, 2007.
Znajdź pełny tekst źródłaCzęści książek na temat "Dendritic cell"
Tew, John G. "Follicular Dendritic Cells and Dendritic Cell Nomenclature". W Advances in Experimental Medicine and Biology, 467–68. Boston, MA: Springer US, 1993. http://dx.doi.org/10.1007/978-1-4615-2930-9_78.
Pełny tekst źródłaRosenblatt, Jacalyn, i David Avigan. "Dendritic Cells". W Allogeneic Stem Cell Transplantation, 807–54. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-59745-478-0_45.
Pełny tekst źródłaAvigan, David. "Dendritic Cells". W Allogeneic Stem Cell Transplantation, 411–38. Totowa, NJ: Humana Press, 2003. http://dx.doi.org/10.1007/978-1-59259-333-0_26.
Pełny tekst źródłaYlagan, Lourdes R. "Dendritic Cell Tumors". W Dendritic Cells in Cancer, 365–74. New York, NY: Springer US, 2009. http://dx.doi.org/10.1007/978-0-387-88611-4_24.
Pełny tekst źródłaKreitinger, Joanna M., i David M. Shepherd. "Dendritic Cell Assays". W Methods in Molecular Biology, 243–53. New York, NY: Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-8549-4_16.
Pełny tekst źródłaDhodapkar, Madhav V. "Dendritic Cell Vaccines". W Handbook of Cancer Vaccines, 317–29. Totowa, NJ: Humana Press, 2004. http://dx.doi.org/10.1007/978-1-59259-680-5_21.
Pełny tekst źródłaSabado, Rachel Lubong, Marcia Meseck i Nina Bhardwaj. "Dendritic Cell Vaccines". W Vaccine Design, 763–77. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-3387-7_44.
Pełny tekst źródłaThurnher, Martin. "Dendritic Cell Vaccines". W Allergy Frontiers: Future Perspectives, 267–76. Tokyo: Springer Japan, 2010. http://dx.doi.org/10.1007/978-4-431-99365-0_17.
Pełny tekst źródłaSchachter, Levanto. "Dendritic Cell Vaccines". W Blood and Marrow Transplant Handbook, 895–903. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-53626-8_56.
Pełny tekst źródłaYamanaka, Ryuya, i Koji Kajiwara. "Dendritic Cell Vaccines". W Advances in Experimental Medicine and Biology, 187–200. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-3146-6_15.
Pełny tekst źródłaStreszczenia konferencji na temat "Dendritic cell"
Lutfi, Riad, John R. Ledford, Ping Zhou i Kristen Page. "Dendritic Cell Reprogramming Of Airway Epithelial Cell Responses". W American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1065.
Pełny tekst źródłaBraun, Armin, Emma Spies, Sabine Rochlitzer i Sabrina Voedisch. "Neuropeptides Influence Airway Dendritic Cell Behavior". W American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2155.
Pełny tekst źródłaDesch, Ashley N., Gwendalyn J. Randolph, Robert J. Mason, Peter M. Henson i Claudia Jakubzick. "Pulmonary Dendritic Cell Specificity Of Efferocytosis". W American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a2838.
Pełny tekst źródłaZhang, Yujie. "Dendritic cell vaccine in cancer immunotherapy". W Third International Conference on Biological Engineering and Medical Science (ICBioMed2023), redaktor Alan Wang. SPIE, 2024. http://dx.doi.org/10.1117/12.3013149.
Pełny tekst źródłaXu, Q. Y., W. M. Feng i B. C. Liu. "3D Stochastic Modeling of As-Cast Microstructure for Aluminum Alloy Casting". W ASME 2002 International Mechanical Engineering Congress and Exposition. ASMEDC, 2002. http://dx.doi.org/10.1115/imece2002-32894.
Pełny tekst źródłaStibor, Thomas, Robert Oates, Graham Kendall i Jonathan M. Garibaldi. "Geometrical insights into the dendritic cell algorithm". W the 11th Annual conference. New York, New York, USA: ACM Press, 2009. http://dx.doi.org/10.1145/1569901.1570072.
Pełny tekst źródłaFu, Jun, Yiwen Liang, Chengyu Tan i Xiaofei Xiong. "Detecting Software Keyloggers with Dendritic Cell Algorithm". W 2010 International Conference on Communications and Mobile Computing (CMC). IEEE, 2010. http://dx.doi.org/10.1109/cmc.2010.269.
Pełny tekst źródłaCrockett, Caroline, Elizabeth Orrico, Sara McArdle, Klaus Ley i Scott T. Acton. "Momentum measure for quantifying dendritic cell movement". W 2015 49th Asilomar Conference on Signals, Systems and Computers. IEEE, 2015. http://dx.doi.org/10.1109/acssc.2015.7421275.
Pełny tekst źródłaZhou, Wen, Yiwen Liang, Hongbin Dong, Chengyu Tan, Zhenhua Xiao i Weiwei Liu. "A Numerical Differentiation Based Dendritic Cell Model". W 2017 IEEE 29th International Conference on Tools with Artificial Intelligence (ICTAI). IEEE, 2017. http://dx.doi.org/10.1109/ictai.2017.00167.
Pełny tekst źródłaGreensmith, Julie, i Longzhi Yang. "TwoDCA: A 2-Dimensional Dendritic Cell Algorithm with Dynamic Cell Migration". W 2022 IEEE Congress on Evolutionary Computation (CEC). IEEE, 2022. http://dx.doi.org/10.1109/cec55065.2022.9870441.
Pełny tekst źródłaRaporty organizacyjne na temat "Dendritic cell"
Easoz, J., R. Rosey, R. Campbell, R. Rupnik, R. Sprecace, P. Piotrowski, J. McHugh i R. Seidensticker. Dendritic web silicon photovoltaic cell research. Office of Scientific and Technical Information (OSTI), maj 1990. http://dx.doi.org/10.2172/6904462.
Pełny tekst źródłaAkporiaye, Emmanuel T. Tumor-Mediated Suppression of Dendritic Cell Vaccines. Fort Belvoir, VA: Defense Technical Information Center, kwiecień 2004. http://dx.doi.org/10.21236/ada428247.
Pełny tekst źródłaMathis, James M. Dendritic Cell-Based Genetic Immunotherapy for Ovarian Cancer. Fort Belvoir, VA: Defense Technical Information Center, grudzień 2007. http://dx.doi.org/10.21236/ada491946.
Pełny tekst źródłaMathis, James M. Dendritic Cell-Based Genetic Immunotherapy for Ovarian Cancer. Fort Belvoir, VA: Defense Technical Information Center, grudzień 2008. http://dx.doi.org/10.21236/ada518244.
Pełny tekst źródłaMathis, James M. Dendritic Cell-Based Genetic Immunotherapy for Ovarian Cancer. Fort Belvoir, VA: Defense Technical Information Center, grudzień 2005. http://dx.doi.org/10.21236/ada462730.
Pełny tekst źródłaGilboa, Eli. Immunotherapy of Breast with Tumor RNA Transfected Dendritic Cell Vaccines. Fort Belvoir, VA: Defense Technical Information Center, wrzesień 2001. http://dx.doi.org/10.21236/ada398155.
Pełny tekst źródłaBaar, Joseph. Dendritic Cell-Based Immunotherapy of Breast Cancer: Modulation by CpG. Fort Belvoir, VA: Defense Technical Information Center, wrzesień 2004. http://dx.doi.org/10.21236/ada431640.
Pełny tekst źródłaDewhurst, Stephen. Dendritic Cell-Targeted Phage Vectors for Breast Cancer Vaccine Development. Fort Belvoir, VA: Defense Technical Information Center, czerwiec 2003. http://dx.doi.org/10.21236/ada417050.
Pełny tekst źródłaRamanathapuram, Lalitha V., i Emmanuel T. Akporiaye. Vitamin E Succinate as an Adjuvant for Dendritic Cell-Based Vaccines. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2005. http://dx.doi.org/10.21236/ada443920.
Pełny tekst źródłaOdegard, Elin. Dendritic Cell-Targeted Vaccinations: A Promising Immunotherapeutic Approach to Cancer Treatment. Portland State University Library, styczeń 2015. http://dx.doi.org/10.15760/honors.148.
Pełny tekst źródła